These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 22342241)

  • 1. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
    Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
    Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
    Esplugas S; Bila DM; Krause LG; Dezotti M
    J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan.
    Lin AY; Lin CF; Tsai YT; Lin HH; Chen J; Wang XH; Yu TH
    Water Sci Technol; 2010; 62(10):2450-8. PubMed ID: 21076233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.
    Padhye LP; Yao H; Kung'u FT; Huang CH
    Water Res; 2014 Mar; 51():266-76. PubMed ID: 24262763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management.
    Oulton RL; Kohn T; Cwiertny DM
    J Environ Monit; 2010 Nov; 12(11):1956-78. PubMed ID: 20938541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.
    Wu Q; Shi H; Adams CD; Timmons T; Ma Y
    Sci Total Environ; 2012 Nov; 439():18-25. PubMed ID: 23059968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozone and biofiltration as an alternative to reverse osmosis for removing PPCPs and micropollutants from treated wastewater.
    Lee CO; Howe KJ; Thomson BM
    Water Res; 2012 Mar; 46(4):1005-14. PubMed ID: 22202904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate VI, and ozone) and non-selective oxidants (hydroxyl radical).
    Lee Y; von Gunten U
    Water Res; 2010 Jan; 44(2):555-66. PubMed ID: 20015530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of adsorption capacity for pharmaceuticals, personal care products and endocrine disrupting chemicals onto various adsorbent materials.
    Bunmahotama W; Lin TF; Yang X
    Chemosphere; 2020 Jan; 238():124658. PubMed ID: 31548174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and treatment trials of endocrine disrupting chemicals (EDCs) in wastewaters.
    Jiang JQ; Yin Q; Zhou JL; Pearce P
    Chemosphere; 2005 Oct; 61(4):544-50. PubMed ID: 16202808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination and occurrence of organic micropollutants in reverse osmosis treatment for advanced water reuse.
    Gomez V; Majamaa K; Pocurull E; Borrull F
    Water Sci Technol; 2012; 66(1):61-71. PubMed ID: 22678201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review.
    Liu ZH; Kanjo Y; Mizutani S
    Sci Total Environ; 2009 Jan; 407(2):731-48. PubMed ID: 18992918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
    Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
    Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes.
    Ozaki H; Ikejima N; Shimizu Y; Fukami K; Taniguchi S; Takanami R; Giri RR; Matsui S
    Water Sci Technol; 2008; 58(1):73-81. PubMed ID: 18653939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters.
    Hijosa-Valsero M; Matamoros V; Sidrach-Cardona R; Martín-Villacorta J; Bécares E; Bayona JM
    Water Res; 2010 Jun; 44(12):3669-78. PubMed ID: 20494393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.